U.S. flag

An official website of the United States government

PubAg

Main content area

You searched for: Author "Nakayasu, Chihaya" Remove constraint Author: "Nakayasu, Chihaya" Publication Year 2018 Remove constraint Publication Year: 2018 Subject Seriola quinqueradiata Remove constraint Subject: Seriola quinqueradiata Subject antigens Remove constraint Subject: antigens Subject Seriola dumerili Remove constraint Subject: Seriola dumerili Subject Infectious spleen and kidney necrosis virus Remove constraint Subject: Infectious spleen and kidney necrosis virus Text Availability Citation in PubAg Remove constraint Text Availability: Citation in PubAg
Start Over

Search

1  Search Results

1 entry found
Number of results to display per page

Search Results

1. Antibody profiling using a recombinant protein–based multiplex ELISA array accelerates recombinant vaccine development: Case study on red sea bream iridovirus as a reverse vaccinology model

Author:
Nakayasu, Chihaya,   et al.   ; Matsuyama, Tomomasa; Sano, Natsumi; Takano, Tomokazu; Sakai, Takamitsu; Yasuike, Motoshige; Fujiwara, Atushi; Kawato, Yasuhiko; Kurita, Jun; Yoshida, Kazunori; Shimada, Yukinori;     Show all 11 Authors
Source:
Vaccine 2018 v.36 no.19 pp. 2643-2649
ISSN:
0264-410X
Subject:
Infectious spleen and kidney necrosis virus; Seriola dumerili; Seriola quinqueradiata; antibodies; antigens; blood serum; case studies; enzyme-linked immunosorbent assay; fish; genes; immune response; models; pathogens; prediction; protective effect; recombinant vaccines; screening; sorbents; vaccine development
Abstract:
... Predicting antigens that would be protective is crucial for the development of recombinant vaccine using genome based vaccine development, also known as reverse vaccinology. High-throughput antigen screening is effective for identifying vaccine target genes, particularly for pathogens for which minimal antigenicity data exist. Using red sea bream iridovirus (RSIV) as a research model, we developed ...
DOI:
10.1016/j.vaccine.2018.03.059